WATSON 954 (Reclipsen desogestrel 0.15 mg / ethinyl estradiol 0.03 mg)
Generic Name: desogestrel/ethinyl estradiol
Pill imprint WATSON 954 has been identified as Reclipsen desogestrel 0.15 mg / ethinyl estradiol 0.03 mg.
Reclipsen is used in the treatment of polycystic ovary syndrome; endometriosis; birth control; abnormal uterine bleeding; gonadotropin inhibition and belongs to the drug class contraceptives. Not for use in pregnancy. Reclipsen desogestrel 0.15 mg / ethinyl estradiol 0.03 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 954
- Generic Name:
- desogestrel/ethinyl estradiol
- desogestrel 0.15 mg / ethinyl estradiol 0.03 mg
- Prescription only
- Drug Class:
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
D&C Yellow No. 10
FD&C Blue No. 2
More about Reclipsen (desogestrel / ethinyl estradiol)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.